AAAAAA
Results:
1-11
|
Results: 11
Authors:
Ragde, H
Korb, L
Citation: H. Ragde et L. Korb, Brachytherapy for clinically localized prostate cancer, SEM SURG ON, 18(1), 2000, pp. 45-51
Authors:
Ragde, H
Citation: H. Ragde, Simultaneous irradiation for prostate cancer: Intermediate results with modern techniques - Comment, J UROL, 164(3), 2000, pp. 742-742
Authors:
Ragde, H
Korb, LJ
Elgamal, AA
Grado, GL
Nadir, BS
Citation: H. Ragde et al., Modern prostate brachytherapy - Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up, CANCER, 89(1), 2000, pp. 135-141
Authors:
Ragde, H
Grado, GL
Nadir, B
Elgamal, AA
Citation: H. Ragde et al., Modern prostate brachytherapy, CA-A CANC J, 50(6), 2000, pp. 380-393
Authors:
Tjoa, BA
Simmons, SJ
Elgamal, A
Rogers, M
Ragde, H
Kenny, GM
Troychak, MJ
Boynton, AL
Murphy, GP
Citation: Ba. Tjoa et al., Follow-up evaluation of a phase II prostate cancer vaccine trial, PROSTATE, 40(2), 1999, pp. 125-129
Authors:
Simmons, SJ
Tjoa, BA
Rogers, M
Elgamal, A
Kenny, GM
Ragde, H
Troychak, MJ
Boynton, AL
Murphy, GP
Citation: Sj. Simmons et al., GM-CSF as a systemic adjuvant in a phase II prostate cancer vaccine trial, PROSTATE, 39(4), 1999, pp. 291-297
Authors:
Murphy, GP
Tjoa, BA
Simmons, SJ
Ragde, H
Rogers, M
Elgamal, A
Kenny, GM
Troychak, MJ
Salgaller, ML
Boynton, AL
Citation: Gp. Murphy et al., Phase II prostate cancer vaccine trial: Report of a study involving 37 patients with disease recurrence following primary treatment, PROSTATE, 39(1), 1999, pp. 54-59
Authors:
Murphy, GP
Tjoa, BA
Simmons, SJ
Jarisch, J
Bowes, VA
Ragde, H
Rogers, M
Elgamal, A
Kenny, GM
Cobb, OE
Ireton, RC
Troychak, MJ
Salgaller, ML
Boynton, AL
Citation: Gp. Murphy et al., Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: A phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease, PROSTATE, 38(1), 1999, pp. 73-78
Authors:
Ragde, H
Korb, L
Elgamal, AA
Citation: H. Ragde et al., Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high gleason grade prostate carcinoma - Reply, CANCER, 85(5), 1999, pp. 1205-1206
Authors:
Ragde, H
Korb, L
Citation: H. Ragde et L. Korb, Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high gleason grade prostate carcinoma - Reply, CANCER, 85(5), 1999, pp. 1207-1208
Authors:
Tapen, EM
Blasko, JC
Grimm, PD
Ragde, H
Luse, R
Clifford, S
Sylvester, J
Griffin, TW
Citation: Em. Tapen et al., Reduction of radioactive seed embolization to the lung following prostate brachytherapy, INT J RAD O, 42(5), 1998, pp. 1063-1067
Risultati:
1-11
|